Valued Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9K Buy
43
+8
+23% +$533 ﹤0.01% 588
2026
Q1
$2.2K Buy
35
+34
+3,400% +$2.37K ﹤0.01% 553
2025
Q4
$67 Sell
1
-1
-50% -$65 ﹤0.01% 628
2025
Q3
$135 Buy
+2
New +$158 ﹤0.01% 594
2024
Q4
Sell
-6
Closed -$403 656
2024
Q3
$403 Sell
6
-23
-79% -$1.89K ﹤0.01% 548
2024
Q2
$3.29K Hold
29
﹤0.01% 315
2024
Q1
$4.02K Buy
29
+1
+4% +$126 ﹤0.01% 271
2023
Q4
$2.61K Buy
+28
New +$2.86K ﹤0.01% 274

Other funds holding DXCM

Valued Wealth Advisors's DXCM Position: Q2 2026 in Review

Valued Wealth Advisors increased its DexCom (DXCM) stake by 23% in Q2 2026, buying an estimated $533 and bringing the position to 43 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Valued Wealth Advisors first reported a position in DXCM in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.02K in Q1 2024. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Valued Wealth Advisors held 43 shares of DexCom worth $2.9K as of Q2 2026.
  • Valued Wealth Advisors bought 8 DexCom shares in Q2 2026, an estimated $533.
  • DexCom made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #588 holding.
  • Valued Wealth Advisors first reported a position in DexCom in Q4 2023 and has held it in 8 quarters since.
  • Valued Wealth Advisors's DexCom position peaked at $4.02K in Q1 2024.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.